AlphAIAlphAI — Financial news for AI agents
investing.comSEP 82 min read

Why is Doximity stock slipping today?

Doximity stock fell 0.8% in pre-market trading after Freedom Capital downgraded it to Hold with a $27 price target, citing reduced EBITDA guidance. Analysts noted heavy AI investment spending may pressure near-term profitability, while broader market sentiment is mildly risk-off.

Original reporting
investing.com
Published Sep 8, 2026, 11:44 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 11:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMarket movers
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$DOCS
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

Med
01

Why it matters

The downgrade reflects concerns over margin pressure despite revenue growth, influencing short‑term price action.

02

Market read

Analyst downgrade amid AI spending concerns triggers modest sell‑off in a high‑growth health‑tech name.

03

What to watch

Potential stabilization of pharma ad spend could support revenue later in the year.

Relevance 6/10Novelty 7/10Timing: pre‑market today

Background

Doximity posted Q1 results ahead of estimates but trimmed FY EBITDA outlook due to higher AI spend.

Market effects

Sector

Growth‑oriented health‑tech stocks may face broader risk‑off pressure.

Regional

U.S. equities edged lower, adding to a mildly risk‑off tone.

Global

Limited; impact confined to U.S. digital health sector.

Counterpoint

What could challenge this read

If AI investment drives long‑term market share, the downgrade may be premature.

Key entities

  • Analyst
    Freedom Capital

    Research firm that issued the downgrade.

  • Company
    Doximity

    Digital health platform.

Read at source← All news

Related articles

SEP 14
MedAI 8/10

Doximity’s ex-chief revenue officer to pay nearly $500K to SEC: Trial Balance

Doximity's former chief revenue officer, Paul Jorgensen, was ordered to pay $490,000 to the SEC for insider trading. He sold shares based on nonpublic information ahead of negative earnings announcements, avoiding losses and making $2.2 million in profits. Jorgensen was also sentenced to 26 months in prison and ordered to forfeit $2.5 million in a parallel criminal case.

finance.yahoo.com2 min
SEP 8
$DOCSMed

Doximity stock falls as Freedom Capital cuts to hold

Doximity Inc (DOCS) shares dropped 5.6% after Freedom Capital downgraded it to Hold, raising its price target to $27. The company beat Q1 estimates, increased full-year revenue guidance, but lowered EBITDA outlook due to AI investment. Freedom Capital noted strong AI search traction but margin concerns and core business softening.

investing.com1 min
AUG 16
$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.

aol.com6 min
AUG 14
$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.

fool.com7 min
AUG 11
$DOCSMed

Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool

Doximity (DOCS) shares jumped in overnight trading after CEO Jeffrey Tangney said the company’s new AI search tool generates over 10 times the revenue versus its operating cost. The stock later closed up 33% on Friday. Doximity reported Q1 revenue of $156.6M and adjusted EBITDA of $74.8M, and raised full-year guidance to $671M-$681M. Wells Fargo later downgraded to underweight.

tikr.com6 min